Welcome to our dedicated page for Carecloud news (Ticker: CCLD), a resource for investors and traders seeking the latest updates and insights on Carecloud stock.
CareCloud, Inc. (Nasdaq: CCLD) generates frequent news as a healthcare technology company focused on AI-powered and technology-enabled solutions for medical practices, hospitals, and health systems. Its announcements highlight developments in revenue cycle management (RCM), electronic health records (EHR), practice management (PM), analytics, patient experience management (PXM), digital health, and artificial intelligence (AI).
News coverage for CareCloud often features product launches and AI initiatives. Recent examples include the full launch of stratusAI Desk Agent, an agentic AI phone receptionist designed to automate patient phone interactions and integrate with EHR and PM systems, and updates on stratusAI Voice Audit, a conversational intelligence platform that analyzes patient calls and provides performance metrics and insights.
Investors and healthcare professionals can also follow acquisition and partnership announcements. CareCloud has reported acquiring Medsphere Systems Corporation, bringing the Wellsoft emergency department information system into its portfolio, and entering into an agreement to acquire HFMA’s MAP App, a hospital benchmarking tool for revenue cycle performance, supported by a long-term joint marketing partnership with the Healthcare Financial Management Association.
Another major category of news involves financial results, guidance, and capital structure updates. CareCloud issues quarterly earnings releases, updates revenue guidance, and discusses profitability, cash flow, and the impact of acquisitions. The company also publishes information on preferred stock dividends, including its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (CCLDO) and plans to address accumulated dividends through structured payment programs.
Governance and regulatory updates, such as SEC filings describing material events, board composition changes, and Nasdaq listing rule compliance matters, appear in the news flow as well. For ongoing insight into how CareCloud is evolving its AI strategy, expanding in the hospital IT market, and managing its financial profile, readers can use this page as a centralized feed of company press releases and related coverage.
CareCloud (Nasdaq: CCLD, CCLDO) announced monthly cash dividends for its 8.75% Series A and Series B cumulative perpetual preferred shares for October, November and December 2025.
Key facts: monthly dividend per share $0.18229 for each series; Series A holders receive an additional payment tied to a prior 11% rate that equals $0.04688 (Oct), $0.01719 (Nov) and $0.00 (Dec); ex-dividend and record dates are the last day of each month (Oct 31, Nov 30, Dec 31, 2025); payment dates are Nov 17, 2025, Dec 15, 2025 and Jan 15, 2026.
Dividends are cumulative, calculated at 8.75% per annum on the $25 liquidation preference (equivalent to $2.1875 per annum per share). Previously converted Series A holders who converted on March 6, 2025 are not eligible for these payments.
CareCloud (NASDAQ: CCLD) has announced a definitive agreement to acquire HFMA's MAP App, a leading hospital benchmarking tool, with the deal set to close on October 1, 2025. The acquisition includes a long-term joint marketing agreement with the Healthcare Financial Management Association (HFMA).
MAP App, developed by HFMA and used by top hospitals nationwide, specializes in benchmarking and measuring revenue cycle management performance. CareCloud plans to enhance the tool's capabilities with AI-driven insights through its AI Center of Excellence, building on synergies from its recent Medsphere hospital IT business acquisition.
The partnership aims to expand MAP App's reach and capabilities while leveraging HFMA's network of 140,000 members. The acquisition is not expected to have a material financial impact on CareCloud in 2025.
CareCloud (NASDAQ: CCLD) has unveiled Marketware, a physician relationship management and analytics platform acquired through its recent Medsphere acquisition. The platform helps hospitals strengthen physician alignment, optimize referral networks, and drive measurable growth.
Marketware's key features include tracking referral patterns, reducing network leakage, and providing actionable intelligence through interactive dashboards. The platform is being integrated with CareCloud's AI Center of Excellence, revenue cycle management tools, and inpatient EHR solutions.
A live demonstration of Marketware is scheduled for October 8, 2025, at 1:00 PM ET, where hospitals can explore the platform's capabilities and learn about CareCloud's growth vision.
CareCloud (NASDAQ: CCLD) has secured a new $10 million credit facility with Provident Bank, with approximately $8.3 million drawn at closing to support the recent Medsphere Systems Corporation acquisition. The facility, closed on September 3, 2025, replaces a previous Wells Fargo promissory note with more favorable terms.
The credit facility features an interest rate of SOFR plus 3% (currently under 7.5%) and a two-year term. This financing supports the $16.5 million Medsphere acquisition, of which $8.25 million was paid at closing from internal cash flow. CareCloud plans to fully pay down the Medsphere-related obligation by mid-2026 through internally generated cash flow.
CareCloud (NASDAQ: CCLD) has raised its 2025 revenue guidance following the acquisition of Medsphere Systems Corporation's business assets. The company now projects 2025 revenue of $116-118 million, up from the previous guidance of $111-114 million. For 2026, CareCloud anticipates revenue of $128-130 million.
The improved outlook reflects increased scale and expanded participation in the hospital IT market, with growth driven by cross-selling opportunities, expanded hospital adoption, and continued AI innovation. While Adjusted EBITDA guidance remains unchanged, GAAP EPS will be impacted by higher non-cash amortization expense from the acquisition.
CareCloud (Nasdaq: CCLD) has completed the acquisition of Medsphere Systems Corporation, marking a significant expansion into the hospital IT market. The deal brings together Medsphere's extensive client base of over 600 healthcare facilities across 50 states with CareCloud's AI and R&D capabilities.
The acquisition includes Medsphere's comprehensive hospital IT ecosystem featuring CareVue (integrated inpatient EHR), RCM Cloud (revenue cycle management), Wellsoft (Emergency Department Information System), HealthLine (supply chain management), ChartLogic (ambulatory EHR), and managed IT services. This strategic move positions CareCloud to provide affordable, AI-enhanced healthcare technology solutions specifically targeted at small and mid-sized hospitals.
CareCloud (Nasdaq: CCLD) reported strong Q2 2025 financial results, marking its first quarter of positive GAAP EPS since going public in 2014. The company achieved GAAP net income of $2.9 million, a 73% increase from Q2 2024, and revenue of $27.4 million.
Key highlights include the launch of their AI Center of Excellence, scaling to 500 team members by year-end, and the completion of two acquisitions in 2025. The company reaffirmed its 2025 guidance, projecting revenue of $111-114 million, Adjusted EBITDA of $26-28 million, and GAAP EPS of $0.10-0.13.
Year-to-date performance showed strong growth with GAAP net income up 238% to $4.9 million and free cash flow increasing 85% to $9.0 million compared to the same period last year.
CareCloud (Nasdaq: CCLD) has achieved ONC Health IT Certification for its electronic health record (EHR) platform specifically designed for Critical Access Hospitals (CAHs). This certification, granted on August 1, 2025, enables CareCloud to enter the $1.5 billion+ inpatient EHR market serving over 1,300 CAHs.
The company's AI-powered, cloud-based platform addresses the unique needs of rural hospitals, offering certified compliance, support for various workflows, and built-in AI tools. According to Black Book Research, over 50% of rural and CAHs plan to replace their legacy EHR systems by 2026, presenting a significant market opportunity for CareCloud's modern solution.
CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for July, August, and September 2025.
The company will pay $0.18229 per share monthly dividend for both Series A and B Preferred Stock. Series A holders will receive an additional $0.04688 per share payment due to historical rate adjustments. Both series carry an 8.75% annual dividend rate on the $25.00 per share liquidation preference. Dividends will be paid on August 15, September 15, and October 15, 2025.
Series A holders converted before March 6, 2025, are not eligible for these payments as they have already received their dividends in shares.CareCloud (Nasdaq: CCLD) has launched an AI-driven, fully integrated dermatology Electronic Health Record (EHR) system targeting the $9 billion U.S. dermatology services market. The cloud-based platform combines AI-powered documentation, advanced image management, and seamless integration with practice management, revenue cycle management (RCM), and telehealth services.
The comprehensive solution features AI-powered charting, customizable templates, advanced image management, integrated telehealth capabilities, optimized billing, and seamless interoperability with labs and pharmacies. The platform aims to streamline clinical workflows, enhance patient engagement, and improve financial outcomes for dermatology practices of all sizes.
FAQ
What is the current stock price of Carecloud (CCLD)?
What is the market cap of Carecloud (CCLD)?
